• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人β冠状病毒刺突蛋白的比较研究:结构、功能与治疗学。

A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.

机构信息

School of Computational and Integrative Sciences, Jawaharlal Nehru University, New Delhi, India.

出版信息

Arch Virol. 2021 Mar;166(3):697-714. doi: 10.1007/s00705-021-04961-y. Epub 2021 Jan 22.

DOI:10.1007/s00705-021-04961-y
PMID:33483791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7821988/
Abstract

Coronaviruses are the paradigm of emerging 21 century zoonotic viruses, triggering numerous outbreaks and a severe global health crisis. The current COVID-19 pandemic caused by SARS-CoV-2 has affected more than 51 million people across the globe as of 12 November 2020. The crown-like spikes on the surface of the virion are the unique structural feature of viruses in the family Coronaviridae. The spike (S) protein adopts distinct conformations while mediating entry of the virus into the host. This multifunctional protein mediates the entry process by recognizing its receptor on the host cell, followed by the fusion of the viral membrane with the host cell membrane. This review article focuses on the structural and functional comparison of S proteins of the human betacoronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here, we review the current state of knowledge about receptor recognition, the membrane fusion mechanism, structural epitopes, and glycosylation sites of the S proteins of these viruses. We further discuss various vaccines and other therapeutics such as monoclonal antibodies, peptides, and small molecules based on the S protein of these three viruses.

摘要

冠状病毒是 21 世纪新兴人畜共患病病毒的典范,引发了众多疫情爆发和严重的全球健康危机。截至 2020 年 11 月 12 日,由严重急性呼吸综合征冠状病毒 2 (SARS-CoV-2)引起的当前 COVID-19 大流行已经影响了全球超过 5100 万人。病毒粒子表面的冠状刺突是冠状病毒科病毒的独特结构特征。刺突(S)蛋白在介导病毒进入宿主的过程中采用不同的构象。这种多功能蛋白通过识别宿主细胞上的受体来介导进入过程,随后病毒膜与宿主细胞膜融合。本文综述了人β冠状病毒、严重急性呼吸综合征冠状病毒(SARS-CoV)、中东呼吸综合征冠状病毒(MERS-CoV)和严重急性呼吸综合征冠状病毒 2(SARS-CoV-2)的 S 蛋白的结构和功能比较。在这里,我们综述了关于这些病毒 S 蛋白的受体识别、膜融合机制、结构表位和糖基化位点的最新知识。我们进一步讨论了基于这三种病毒的 S 蛋白的各种疫苗和其他治疗方法,如单克隆抗体、肽和小分子。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/7821988/6cc75103b7a5/705_2021_4961_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/7821988/a124a5bf7897/705_2021_4961_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/7821988/6c0a7103b3d2/705_2021_4961_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/7821988/b10f736766b3/705_2021_4961_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/7821988/6cc75103b7a5/705_2021_4961_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/7821988/a124a5bf7897/705_2021_4961_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/7821988/6c0a7103b3d2/705_2021_4961_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/7821988/b10f736766b3/705_2021_4961_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0268/7821988/6cc75103b7a5/705_2021_4961_Fig4_HTML.jpg

相似文献

1
A comparative study of human betacoronavirus spike proteins: structure, function and therapeutics.人β冠状病毒刺突蛋白的比较研究:结构、功能与治疗学。
Arch Virol. 2021 Mar;166(3):697-714. doi: 10.1007/s00705-021-04961-y. Epub 2021 Jan 22.
2
Analysis of the Role of N-Linked Glycosylation in Cell Surface Expression, Function, and Binding Properties of SARS-CoV-2 Receptor ACE2.分析 N 连接糖基化在 SARS-CoV-2 受体 ACE2 的细胞表面表达、功能和结合特性中的作用。
Microbiol Spectr. 2021 Oct 31;9(2):e0119921. doi: 10.1128/Spectrum.01199-21. Epub 2021 Sep 8.
3
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
4
Comprehensive Structural and Molecular Comparison of Spike Proteins of SARS-CoV-2, SARS-CoV and MERS-CoV, and Their Interactions with ACE2.全面比较 SARS-CoV-2、SARS-CoV 和 MERS-CoV 的刺突蛋白的结构和分子特征,及其与 ACE2 的相互作用。
Cells. 2020 Dec 8;9(12):2638. doi: 10.3390/cells9122638.
5
Molecular Basis of Pathogenesis of Coronaviruses: A Comparative Genomics Approach to Planetary Health to Prevent Zoonotic Outbreaks in the 21st Century.冠状病毒发病机制的分子基础:以比较基因组学方法研究行星健康,以预防 21 世纪的人畜共患病爆发。
OMICS. 2020 Nov;24(11):634-644. doi: 10.1089/omi.2020.0131. Epub 2020 Sep 16.
6
Man-Specific Lectins from Plants, Fungi, Algae and Cyanobacteria, as Potential Blockers for SARS-CoV, MERS-CoV and SARS-CoV-2 (COVID-19) Coronaviruses: Biomedical Perspectives.植物、真菌、藻类和蓝藻中的人特异性凝集素,作为 SARS-CoV、MERS-CoV 和 SARS-CoV-2(COVID-19)冠状病毒的潜在阻滞剂:生物医学视角。
Cells. 2021 Jun 28;10(7):1619. doi: 10.3390/cells10071619.
7
Dynamics of SARS-CoV-2 Spike Proteins in Cell Entry: Control Elements in the Amino-Terminal Domains.SARS-CoV-2 刺突蛋白在细胞进入中的动力学:氨基末端结构域中的控制元件。
mBio. 2021 Aug 31;12(4):e0159021. doi: 10.1128/mBio.01590-21. Epub 2021 Aug 3.
8
V367F Mutation in SARS-CoV-2 Spike RBD Emerging during the Early Transmission Phase Enhances Viral Infectivity through Increased Human ACE2 Receptor Binding Affinity.SARS-CoV-2 刺突 RBD 中的 V367F 突变增强了与人类 ACE2 受体的结合亲和力,从而提高了病毒的感染性。
J Virol. 2021 Jul 26;95(16):e0061721. doi: 10.1128/JVI.00617-21.
9
The structural basis of accelerated host cell entry by SARS-CoV-2†.SARS-CoV-2 加速宿主细胞进入的结构基础。
FEBS J. 2021 Sep;288(17):5010-5020. doi: 10.1111/febs.15651. Epub 2020 Dec 14.
10
Coronavirus Spike Protein and Tropism Changes.冠状病毒刺突蛋白与嗜性变化
Adv Virus Res. 2016;96:29-57. doi: 10.1016/bs.aivir.2016.08.004. Epub 2016 Sep 13.

引用本文的文献

1
Spectroscopic secondary structure fingerprint of β-variant of SARS-CoV-2 spike glycoprotein.严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突糖蛋白β变体的光谱二级结构指纹图谱。
Eur Biophys J. 2025 Jul 21. doi: 10.1007/s00249-025-01782-8.
2
The viral landscape in metastatic solid cancers.转移性实体癌中的病毒格局。
Heliyon. 2025 Feb 8;11(4):e42548. doi: 10.1016/j.heliyon.2025.e42548. eCollection 2025 Feb 28.
3
Pathomorphological Features of the Novel Coronavirus Disease in Patients with Systemic Amyloidosis.系统性淀粉样变性患者新型冠状病毒病的病理形态学特征

本文引用的文献

1
Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein.严重急性呼吸综合征冠状病毒2刺突糖蛋白的结构、功能及抗原性
Cell. 2020 Dec 10;183(6):1735. doi: 10.1016/j.cell.2020.11.032.
2
Immunoinformatics approach to understand molecular interaction between multi-epitopic regions of SARS-CoV-2 spike-protein with TLR4/MD-2 complex.免疫信息学方法研究 SARS-CoV-2 刺突蛋白多表位区域与 TLR4/MD-2 复合物之间的分子相互作用。
Infect Genet Evol. 2020 Nov;85:104587. doi: 10.1016/j.meegid.2020.104587. Epub 2020 Oct 8.
3
Repurposing Drugs, Ongoing Vaccine, and New Therapeutic Development Initiatives Against COVID-19.
Biomedicines. 2023 Oct 17;11(10):2811. doi: 10.3390/biomedicines11102811.
4
Customizably designed multibodies neutralize SARS-CoV-2 in a variant-insensitive manner.可定制设计的多聚体以一种对变体不敏感的方式中和 SARS-CoV-2。
Front Immunol. 2023 Aug 10;14:1226880. doi: 10.3389/fimmu.2023.1226880. eCollection 2023.
5
SARS-CoV-2 infection and immune responses.严重急性呼吸综合征冠状病毒2型感染与免疫反应。
AIMS Microbiol. 2023 Mar 29;9(2):245-276. doi: 10.3934/microbiol.2023015. eCollection 2023.
6
The Latest Cellular and Molecular Mechanisms of COVID-19 on Non-Lung Organs.新冠病毒对非肺部器官影响的最新细胞和分子机制
Brain Sci. 2023 Feb 27;13(3):415. doi: 10.3390/brainsci13030415.
7
A comparative study on structural proteins of viruses that belong to the identical family.对属于同一病毒家族的病毒结构蛋白的比较研究。
Eur Phys J Spec Top. 2023 Feb 17:1-10. doi: 10.1140/epjs/s11734-023-00791-y.
8
Impaired VEGF-A-Mediated Neurovascular Crosstalk Induced by SARS-CoV-2 Spike Protein: A Potential Hypothesis Explaining Long COVID-19 Symptoms and COVID-19 Vaccine Side Effects?严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白诱导的血管内皮生长因子A(VEGF-A)介导的神经血管串扰受损:一个解释新冠后综合征症状和新冠疫苗副作用的潜在假说?
Microorganisms. 2022 Dec 12;10(12):2452. doi: 10.3390/microorganisms10122452.
9
Conformational Dynamics of the Receptor-Binding Domain of the SARS-CoV-2 Spike Protein.严重急性呼吸综合征冠状病毒2刺突蛋白受体结合域的构象动力学
Biomedicines. 2022 Dec 12;10(12):3233. doi: 10.3390/biomedicines10123233.
10
Ferritin nanocages as efficient nanocarriers and promising platforms for COVID-19 and other vaccines development.铁蛋白纳米笼作为高效的纳米载体,为 COVID-19 和其他疫苗的开发提供了有前途的平台。
Biochim Biophys Acta Gen Subj. 2023 Mar;1867(3):130288. doi: 10.1016/j.bbagen.2022.130288. Epub 2022 Dec 5.
抗2019冠状病毒病的药物重新利用、现有疫苗及新治疗方法研发计划
Front Pharmacol. 2020 Aug 19;11:1258. doi: 10.3389/fphar.2020.01258. eCollection 2020.
4
A SARS-CoV-2 vaccine candidate: cloning and validation.一种新型冠状病毒疫苗候选物:克隆与验证
Inform Med Unlocked. 2020;20:100394. doi: 10.1016/j.imu.2020.100394. Epub 2020 Jul 15.
5
Structures of Human Antibodies Bound to SARS-CoV-2 Spike Reveal Common Epitopes and Recurrent Features of Antibodies.人类抗体与 SARS-CoV-2 刺突结合的结构揭示了常见表位和抗体的反复出现特征。
Cell. 2020 Aug 20;182(4):828-842.e16. doi: 10.1016/j.cell.2020.06.025. Epub 2020 Jun 24.
6
Vulnerabilities in coronavirus glycan shields despite extensive glycosylation.冠状病毒糖萼尽管广泛糖基化,仍存在弱点。
Nat Commun. 2020 May 27;11(1):2688. doi: 10.1038/s41467-020-16567-0.
7
The Current and Future State of Vaccines, Antivirals and Gene Therapies Against Emerging Coronaviruses.针对新型冠状病毒的疫苗、抗病毒药物和基因疗法的现状与未来发展态势
Front Microbiol. 2020 Apr 24;11:658. doi: 10.3389/fmicb.2020.00658. eCollection 2020.
8
Design of Potent Membrane Fusion Inhibitors against SARS-CoV-2, an Emerging Coronavirus with High Fusogenic Activity.针对高融合活性新兴冠状病毒 SARS-CoV-2 的有效膜融合抑制剂设计。
J Virol. 2020 Jul 1;94(14). doi: 10.1128/JVI.00635-20.
9
A human monoclonal antibody blocking SARS-CoV-2 infection.一种人源单克隆抗体阻断 SARS-CoV-2 感染。
Nat Commun. 2020 May 4;11(1):2251. doi: 10.1038/s41467-020-16256-y.
10
Site-specific glycan analysis of the SARS-CoV-2 spike.新冠病毒刺突蛋白的糖基化位点特异性分析。
Science. 2020 Jul 17;369(6501):330-333. doi: 10.1126/science.abb9983. Epub 2020 May 4.